Multiomic Predictors of Short‐Term Weight Loss and Clinical Outcomes During a Behavioral‐Based Weight Loss Intervention

Identifying predictors of weight loss and clinical outcomes may increase understanding of individual variability in weight loss response. We hypothesized that baseline multiomic features, including DNA methylation (DNAme), metabolomics, and gut microbiome, would be predictive of short‐term changes in body weight and other clinical outcomes within a comprehensive weight loss intervention.

[1]  W. Ahrens,et al.  Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention , 2020, Current Obesity Reports.

[2]  Xiong Liu,et al.  Capsaicin has an anti-obesity effect through alterations in gut microbiota populations and short-chain fatty acid concentrations , 2020, Food & nutrition research.

[3]  S. Zeisel,et al.  Precision (Personalized) Nutrition: Understanding Metabolic Heterogeneity. , 2020, Annual review of food science and technology.

[4]  S. Imoto,et al.  Blautia genus associated with visceral fat accumulation in adults 20–76 years of age , 2019, npj Biofilms and Microbiomes.

[5]  H. Vlamakis,et al.  Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide , 2019, Proceedings of the National Academy of Sciences.

[6]  C. Ortega-Loubon,et al.  Obesity and its cardiovascular effects , 2019, Diabetes/metabolism research and reviews.

[7]  H. Hauner,et al.  Impact of Laparoscopic Sleeve Gastrectomy on Gut Permeability in Morbidly Obese Subjects , 2019, Obesity Surgery.

[8]  S. Zeisel.  A Conceptual Framework for Studying and Investing in Precision Nutrition , 2019, Front. Genet..

[9]  L. Pirola,et al.  Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule , 2019, Scientific Reports.

[10]  Troy C. Krzysiak,et al.  An Insulin-Responsive Sensor in the SIRT1 Disordered Region Binds DBC1 and PACS-2 to Control Enzyme Activity. , 2018, Molecular cell.

[11]  Ruomei Han,et al.  Intermittent administration of a fasting-mimicking diet intervenes in diabetes progression, restores β cells and reconstructs gut microbiota in mice , 2018, Nutrition & Metabolism.

[12]  S. Hazen,et al.  Dietary metabolism, the gut microbiome, and heart failure , 2018, Nature Reviews Cardiology.

[13]  B. Palmer,et al.  VOLARE: visual analysis of disease-associated microbiome-immune system interplay , 2018, bioRxiv.

[14]  Eran Elinav,et al.  You are what you eat: diet, health and the gut microbiota , 2018, Nature Reviews Gastroenterology & Hepatology.

[15]  A. Valsesia,et al.  Plasma metabolites and lipids predict insulin sensitivity improvement in obese, nondiabetic individuals after a 2-phase dietary intervention , 2018, The American journal of clinical nutrition.

[16]  A. Goday,et al.  The Gut Microbiome Profile in Obesity: A Systematic Review , 2018, International journal of endocrinology.

[17]  A. Martí,et al.  Guide for Current Nutrigenetic, Nutrigenomic, and Nutriepigenetic Approaches for Precision Nutrition Involving the Prevention and Management of Chronic Diseases Associated with Obesity , 2017, Lifestyle Genomics.

[18]  T. Simmen,et al.  Caught in the act – protein adaptation and the expanding roles of the PACS proteins in tissue homeostasis and disease , 2017, Journal of Cell Science.

[19]  C. Burant,et al.  Impact of weight loss on waist circumference and the components of the metabolic syndrome , 2017, BMJ Open Diabetes Research and Care.

[20]  Anthony C Davison,et al.  Efficient inference for genetic association studies with multiple outcomes , 2016, Biostatistics.

[21]  H. Daniel,et al.  Dietary fat and gut microbiota interactions determine diet-induced obesity in mice , 2016, Molecular metabolism.

[22]  K. Flegal,et al.  Trends in Obesity Among Adults in the United States, 2005 to 2014. , 2016, JAMA.

[23]  C. Eaton,et al.  Epigenome-wide profiling of DNA methylation in paired samples of adipose tissue and blood , 2016, Epigenetics.

[24]  Alexander V. Tyakht,et al.  Gut microbiota and diet in patients with different glucose tolerance , 2015, Endocrine connections.

[25]  D. Gevers,et al.  The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids , 2015, Circulation research.

[26]  K. Shiraki,et al.  Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing , 2015, BMC Gastroenterology.

[27]  J. Donnelly,et al.  Energy intake, nonexercise physical activity, and weight loss in responders and nonresponders: The Midwest Exercise Trial 2 , 2015, Obesity.

[28]  智佳 笠井.  Comparison of the gut microbiota composition between obese and non- obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing , 2015 .

[29]  Kristian Thorlund,et al.  Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. , 2014, JAMA.

[30]  S. Ogino,et al.  The merits of subtyping obesity: one size does not fit all. , 2013, JAMA.

[31]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[32]  J. Moreno-Navarrete,et al.  Targeting the circulating microRNA signature of obesity. , 2013, Clinical chemistry.

[33]  Y. Sanz,et al.  Bacteroides uniformis CECT 7771 Ameliorates Metabolic and Immunological Dysfunction in Mice with High-Fat-Diet Induced Obesity , 2012, PloS one.

[34]  Alexander S. Banks,et al.  Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. , 2012, Physiological reviews.

[35]  E. Steyerberg,et al.  [Regression modeling strategies]. , 2011, Revista espanola de cardiologia.

[36]  J. Freudenheim,et al.  Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. , 2011, The American journal of clinical nutrition.

[37]  S. Qiao,et al.  Neonatal Fc Receptor: From Immunity to Therapeutics , 2010, Journal of Clinical Immunology.

[38]  Harry J. Flint,et al.  Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.

[39]  William Caplan,et al.  Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. , 2007, Journal of the American Dietetic Association.

[40]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[41]  M. Febbraio,et al.  CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK , 2006, Nature Medicine.

[42]  J. Stephens,et al.  Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. , 2005, The Journal of endocrinology.

[43]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[44]  D. Beitz,et al.  Mechanism of cholesterol reduction to coprostanol by Eubacterium coprostanoligenes ATCC 51222 , 1996, Steroids.

[45]  B. Goldstein,et al.  Beneficial health effects of modest weight loss. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.